Chemify is a Glasgow-based digital chemistry company spun out of the University of Glasgow, where Professor Lee Cronin's research group developed Chemputation, a universal chemical programming language combined with robotics and AI that translates digital code into physical molecules. The company says it aims to make chemical design and synthesis as programmable as computing.

Its first Chemifarm, an automated synthesis facility in Maryhill, Glasgow, opened in 2025. Chemify sells molecule design and synthesis to pharmaceutical, biotech and materials partners, including a Zeon Corporation investment and partnership (February 2026), a collaboration with Sanacor on cardiometabolic small molecules (February 2026), and Gates Foundation-funded tuberculosis and malaria drug discovery grants. In 2026 it secured £22M in grants from Scottish Enterprise and the UK Government to fund a second-generation Chemifarm and a Chemify Genesis system, with plans to create up to 300 jobs.

Founder papers published in PNAS and Nature Communications journals in April 2026 were presented as validation of the Chemputation approach. Sources differ on headcount and founding year (2019 in some databases, 2022 per the company).

Note: the chemify.com domain supplied with this request belongs to an unrelated Latvian composites retailer (Kompozītmateriāli / COMPOSITE24). This profile covers the Glasgow company, whose website is chemify.io.